breast cancer

Hammer PM, Enamandram S, Ikeda DM, Lam MM, Wapnir IL, Chamberlain ED, Shaheen S, Caswell-Jin JL, Itakura H, Bean GR. Mammary small cell neuroendocrine carcinomas[...]

LeVee A, Kordic A, Ruel N, Mortimer J, Kang I, McArthur H, Lechner MG, Tsai K. Safety and Clinical Outcomes of Pembrolizumab Standard-Interval Dosing Versus[...]

Li DX, Jarrett T, Ma J, Garcia JF. Anti-Ri Paraneoplastic Neurologic Syndrome in a Patient With Untreated Breast Cancer. Cureus. 2025 Sep 6;17(9):e91743. doi: 10.7759/cureus.91743.[...]

Bower JE, Radin A, Ganz PA, Irwin MR, Cole SW, Petersen L, Asher A, Hurvitz SA, Crespi CM. Inflammation and dimensions of fatigue in women[...]

Kerr KF, Eguchi MM, Shucard H, Drew T, Weaver DL, Elmore JG, Brunyé TT. Effects of Prior Diagnosis on Second Opinions and Pathologist Viewing Behaviors:[...]

Huang SY, Murray M, Rubio A, Okoro N, Sedrak MS, McCloskey SA, Jackson N, Teshome M, Kapoor NS. Impact of Screening Mammography on Breast Cancer[...]

Zhang S, Guclu SB, Lipsyc-Sharf M, Kapoor NS. Pregnancy and breast cancer in young women: current updates and future directions. Ther Adv Med Oncol. 2025[...]

Blasco A, López-Tarruella S, Urruticoechea A, Carrasco E, Spera G, Martín M, Bermejo B, Chap L, Ruiz-Borrego M, Crown J, García-Saenz JA, Chan A, Guerrero-Zotano[...]

Koric A, Chang CE, Lee YA, Wei M, Lee C, Wang J, Hashibe M. Incident depression after breast cancer among older Asian, Native Hawaiian, and[...]

LeVee A, Peluso E, Lechner MG, Ruel N, Mortimer J, Kang I, Tsai K. Efficacy and immune-related adverse events of pembrolizumab with bone-modifying agents in[...]